Total Funding
72
63
Total FundingSeries C raised
Growth Score
1 pts
Heat Score
20 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
35892
Trellis Bioscience is a therapeutic antibody company developing treatments for infectious diseases and oncology indications.
Stote Ellsworth: Chief Technology Officer & Founder- Elisabeth Whitney: COO & CFO
About the Company
Trellis Bioscience develops a technology platform for cellular informatics. The company's technology has applications in the discovery and production of therapeutic monoclonal antibodies. Its cell biology platform provides a direct readout at the single cell level for monitoring activity of diverse cell types and quantifying the impact of
potential therapeutic interventions. The company is based in San Francisco, California.
